Lv1
40 积分 2024-10-19 加入
Survivin (BIRC5): Implications in cancer therapy
1个月前
已完结
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
1个月前
已完结
KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
1个月前
已完结
Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer
2个月前
已完结
Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
2个月前
已完结
Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer
2个月前
已完结
SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer
2个月前
已完结
Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods
4个月前
已完结
Immobilization of bovine hemoglobin on Au nanoparticles/MoS2 nanosheets – Chitosan modified screen-printed electrode as chlorpyrifos biosensor
4个月前
已完结
Noninvasive Precision Screening of Prostate Cancer by Urinary Multimarker Sensor and Artificial Intelligence Analysis
4个月前
已完结
皖公网安备34019202002308
